215 related articles for article (PubMed ID: 38615182)
1. Metformin and risk of hematological cancers in patients with diabetes: a systematic review and meta-analysis.
Wang M; Noghabaei G; Raeisi T; Li D; Alizadeh H; Alizadeh M
Ann Saudi Med; 2024; 44(2):126-134. PubMed ID: 38615182
[TBL] [Abstract][Full Text] [Related]
2. Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies.
Liang H; Ding X; Li L; Wang T; Kan Q; Wang L; Sun T
Crit Care; 2019 Feb; 23(1):50. PubMed ID: 30777119
[TBL] [Abstract][Full Text] [Related]
3. Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis.
Laffusa A; Ciaccio A; Elvevi A; Gallo C; Ratti L; Invernizzi P; Massironi S
Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):241-247. PubMed ID: 36708293
[TBL] [Abstract][Full Text] [Related]
4. Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
Lai IL; You JF; Tsai WS; Hsu YJ; Chern YJ; Wu MY
World J Surg Oncol; 2023 Jul; 21(1):224. PubMed ID: 37491250
[TBL] [Abstract][Full Text] [Related]
5. Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis.
Jung YS; Park CH; Eun CS; Park DI; Han DS
J Gastroenterol Hepatol; 2017 May; 32(5):957-965. PubMed ID: 28449338
[TBL] [Abstract][Full Text] [Related]
6. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
7. Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis.
Campbell JM; Stephenson MD; de Courten B; Chapman I; Bellman SM; Aromataris E
J Alzheimers Dis; 2018; 65(4):1225-1236. PubMed ID: 30149446
[TBL] [Abstract][Full Text] [Related]
8. Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.
Stevens RJ; Ali R; Bankhead CR; Bethel MA; Cairns BJ; Camisasca RP; Crowe FL; Farmer AJ; Harrison S; Hirst JA; Home P; Kahn SE; McLellan JH; Perera R; Plüddemann A; Ramachandran A; Roberts NW; Rose PW; Schweizer A; Viberti G; Holman RR
Diabetologia; 2012 Oct; 55(10):2593-2603. PubMed ID: 22875195
[TBL] [Abstract][Full Text] [Related]
9. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H
Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481
[TBL] [Abstract][Full Text] [Related]
10. Repositioning of diabetes treatments for depressive symptoms: A systematic review and meta-analysis of clinical trials.
Moulton CD; Hopkins CWP; Ismail K; Stahl D
Psychoneuroendocrinology; 2018 Aug; 94():91-103. PubMed ID: 29775878
[TBL] [Abstract][Full Text] [Related]
11. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.
Yin M; Zhou J; Gorak EJ; Quddus F
Oncologist; 2013; 18(12):1248-55. PubMed ID: 24258613
[TBL] [Abstract][Full Text] [Related]
12. Metformin and the risk of neurodegenerative diseases in patients with diabetes: A meta-analysis of population-based cohort studies.
Zhang Y; Zhang Y; Shi X; Han J; Lin B; Peng W; Mei Z; Lin Y
Diabet Med; 2022 Jun; 39(6):e14821. PubMed ID: 35213749
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
Mekuria AN; Ayele Y; Tola A; Mishore KM
J Diabetes Res; 2019; 2019():7676909. PubMed ID: 31828167
[TBL] [Abstract][Full Text] [Related]
14. Metformin prescription and aortic aneurysm: systematic review and meta-analysis.
Yu X; Jiang D; Wang J; Wang R; Chen T; Wang K; Durgahee MSA; Wei X; Cao S
Heart; 2019 Sep; 105(17):1351-1357. PubMed ID: 30936409
[TBL] [Abstract][Full Text] [Related]
15. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
[TBL] [Abstract][Full Text] [Related]
16. Effects of continuous use of metformin on cardiovascular outcomes in patients with type 2 diabetes after acute myocardial infarction: A protocol for systematic review and meta-analysis.
Shen C; Tan S; Yang J
Medicine (Baltimore); 2021 Apr; 100(15):e25353. PubMed ID: 33847633
[TBL] [Abstract][Full Text] [Related]
17. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis.
Ganesh A; Randall MD
Br J Clin Pharmacol; 2022 Jun; 88(6):2642-2656. PubMed ID: 35122284
[TBL] [Abstract][Full Text] [Related]
18. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.
Noto H; Goto A; Tsujimoto T; Noda M
PLoS One; 2012; 7(3):e33411. PubMed ID: 22448244
[TBL] [Abstract][Full Text] [Related]
20. Metformin and health outcomes: An umbrella review of systematic reviews with meta-analyses.
Li X; Celotto S; Pizzol D; Gasevic D; Ji MM; Barnini T; Solmi M; Stubbs B; Smith L; López Sánchez GF; Pesolillo G; Yu Z; Tzoulaki I; Theodoratou E; Ioannidis JPA; Veronese N; Demurtas J
Eur J Clin Invest; 2021 Jul; 51(7):e13536. PubMed ID: 33709434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
